| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |